Treatment of neurological seizures and epilepsy
Management has three parts:
- Immediate treatment of an ongoing seizure
- Emergency treatment of status epilepticus
- Long-term prevention of recurrent seizures
Treatment is guided by seizure type, cause, age, comorbidities, pregnancy potential, adverse effects, and patient preference.
1. Management of an acute seizure
First aid
- Protect the person from injury and time the seizure.
- Move dangerous objects away and cushion the head.
- Do not restrain movements.
- Do not place anything in the mouth or give oral fluids/medicines.
- After convulsions end, position on the side, check breathing, and observe recovery.
- Check blood glucose promptly when feasible.
- Treat reversible causes: hypoglycemia, hypoxia, electrolyte disorder, infection, alcohol/drug withdrawal, stroke, trauma, or missed antiseizure medication.
When to call emergency services
Call urgently if a seizure:
- Lasts 5 minutes or more
- Repeats without full return to consciousness
- Is the first seizure
- Causes injury, occurs in water, or is accompanied by persistent breathing difficulty
- Occurs in pregnancy, diabetes, or is different from the person’s usual seizure pattern
2. Status epilepticus
Convulsive status epilepticus is a seizure lasting at least 5 minutes, or recurrent seizures without recovery of consciousness between seizures. It is a medical emergency. Rapid termination matters because ongoing seizure activity can produce hypoxia, acidosis, hyperthermia, aspiration, rhabdomyolysis, arrhythmia, and neuronal injury. Tintinalli's Emergency Medicine, section “Types of Seizure,” lines 2335-2336.
Initial approach: 0 to 5 minutes
ABC approach
- Airway positioning, suction if required, oxygen, monitoring
- IV or intraosseous access
- Check capillary glucose immediately
- If glucose is low: IV glucose, with thiamine first or alongside in people at risk of malnutrition/alcohol dependence
- Send blood for electrolytes, calcium, magnesium, renal/liver function, blood count, toxicology as appropriate, and antiseizure drug concentrations where relevant
- Look for and treat the precipitating cause
First-line: benzodiazepine
Give promptly:
- IV lorazepam, if IV access is available, or
- IM midazolam, buccal/intranasal midazolam, or rectal diazepam if IV access is not available.
If the seizure persists, a second appropriate benzodiazepine dose may be given according to local protocol. Repeated benzodiazepine doses without effect increase respiratory-depression risk, so escalation should not be delayed. Tintinalli's Emergency Medicine, section “ED Treatment,” lines 2549-2552.
Second-line: longer-acting IV antiseizure medicine
If seizures continue after benzodiazepines, give one of:
- Levetiracetam
- Fosphenytoin/phenytoin
- Sodium valproate
Choice depends on comorbidity and context:
- Avoid or use major caution with phenytoin/fosphenytoin in significant cardiac conduction disease or arrhythmia.
- Avoid valproate in severe liver disease, mitochondrial disease, and where pregnancy-related risks are relevant.
- Levetiracetam has relatively few drug interactions and is often convenient, but dose adjustment may be needed with renal impairment.
Refractory status epilepticus
Persistent seizures despite benzodiazepine plus a suitable second-line agent require ICU care:
- Airway protection and ventilation where necessary
- Continuous EEG where possible
- Anesthetic infusions such as midazolam, propofol, or barbiturate under critical-care supervision
- Intensive investigation for infection, autoimmune encephalitis, stroke, toxic/metabolic causes, or missed structural lesions
3. Long-term treatment of epilepsy
General principles
- Confirm the seizure type and epilepsy syndrome before choosing a drug.
- Monotherapy is preferred initially: start low and titrate gradually.
- If the first appropriate medicine fails because of adverse effects or lack of seizure control, use an alternative appropriate monotherapy.
- If two suitable, adequately tried antiseizure medicines fail, refer to a specialist epilepsy service for drug-resistant epilepsy assessment.
- Do not stop antiseizure medication suddenly, as abrupt withdrawal can precipitate seizures or status epilepticus.
Correct classification matters because some drugs useful for focal epilepsy may worsen some generalized epilepsy syndromes. Katzung's Basic and Clinical Pharmacology, section “Medications Effective for Focal Seizures & Certain Generalized Onset Seizure Types,” line 1039.
A. Focal-onset seizures
Includes focal aware, focal impaired-awareness, and focal-to-bilateral tonic-clonic seizures.
Common first-line monotherapy options
- Lamotrigine
- Levetiracetam
The current
NICE guidance for focal seizures recommends considering lamotrigine or levetiracetam first, with the other as an alternative if the first is unsuccessful.
Other options
- Carbamazepine
- Oxcarbazepine
- Lacosamide
- Zonisamide
- Topiramate
- Brivaracetam
- Perampanel
Important adverse-effect points
- Lamotrigine: risk of rash, including rare severe cutaneous reactions. Titrate slowly.
- Levetiracetam: irritability, agitation, low mood, behavioral changes.
- Carbamazepine/oxcarbazepine: hyponatremia, rash, drug interactions; carbamazepine can aggravate some generalized seizures.
- Topiramate: cognitive slowing, weight loss, renal stones, metabolic acidosis; important pregnancy-related risk considerations.
B. Generalized tonic-clonic seizures
Potential monotherapy options include:
- Sodium valproate
- Lamotrigine
- Levetiracetam
Valproate is highly effective for many generalized epilepsies, but it has major fetal risks and other adverse effects. It should generally be avoided in women and girls who may become pregnant unless no suitable alternative is effective and strict regulatory pregnancy-prevention measures are met. The
updated NICE guideline emphasizes individualized discussion of valproate benefits, reproductive risks, and current safety restrictions.
C. Absence seizures
- Ethosuximide: preferred when absence seizures occur alone
- Valproate: useful if absence seizures coexist with generalized tonic-clonic or myoclonic seizures
- Lamotrigine: alternative option
Carbamazepine, phenytoin, tiagabine, and vigabatrin can worsen absence or other generalized seizure types in some patients. Katzung's Basic and Clinical Pharmacology, section “Status Epilepticus,” lines 1632-1633.
D. Myoclonic seizures and juvenile myoclonic epilepsy
Common options:
- Valproate, if appropriate
- Levetiracetam
- Lamotrigine
- Topiramate
Avoid sodium-channel medicines such as carbamazepine and phenytoin in many generalized myoclonic epilepsies because they may worsen myoclonus.
E. Atonic, tonic, and Lennox-Gastaut syndrome seizures
Treatment often requires specialist combination therapy. Options may include:
- Valproate
- Lamotrigine
- Clobazam
- Rufinamide
- Topiramate
- Cannabidiol in selected syndromes and settings
- Ketogenic dietary therapy
- Vagus-nerve stimulation or corpus callosotomy in selected drug-resistant cases
4. Drug-resistant epilepsy
Epilepsy is generally considered drug-resistant after failure of two appropriately selected and tolerated antiseizure medication regimens to achieve sustained seizure freedom.
Refer early to a specialist epilepsy center for:
- Video-EEG monitoring
- High-resolution epilepsy-protocol MRI
- Neuropsychological assessment
- Surgical evaluation
- Genetic or autoimmune evaluation where indicated
Non-drug options
- Epilepsy surgery: potentially curative for an identifiable, resectable seizure focus, especially temporal lobe epilepsy.
- Vagus nerve stimulation
- Responsive neurostimulation
- Deep brain stimulation
- Ketogenic or modified Atkins diet, particularly useful in selected children and some adults.
5. Treat the cause
Long-term antiseizure treatment is not always needed after a provoked seizure. Correct the cause, for example:
- Hypoglycemia
- Hyponatremia or hypocalcemia
- Alcohol withdrawal
- CNS infection
- Medication toxicity
- Acute stroke or head injury
After a single unprovoked seizure, chronic treatment is individualized according to recurrence risk, EEG findings, MRI abnormalities, neurologic examination, and patient circumstances. Goldman-Cecil Medicine, section “Single Unprovoked Seizures,” line 21.
6. Lifestyle, safety, and follow-up
- Take medication consistently and avoid abrupt withdrawal.
- Identify triggers: sleep deprivation, alcohol excess, missed doses, recreational drugs, and illness.
- Discuss driving restrictions according to local law.
- Prefer showers over unsupervised baths; avoid swimming alone, heights, open flames, and hazardous machinery if seizures are uncontrolled.
- Discuss contraception, pre-pregnancy planning, and folic acid with a neurologist before conception.
- Provide a seizure action plan and educate family/caregivers on rescue medication where prescribed.
Recent systematic reviews exist on treatment options, but they do not change the central principle: accurate seizure classification, prompt emergency treatment of prolonged seizures, and individually selected antiseizure therapy remain the basis of care.